| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 06/26/2003 | US20030118635 Polynucleotide binding complexes comprising sterols and saponins |
| 06/26/2003 | US20030118600 Transfer compounds, production and use thereof |
| 06/26/2003 | US20030118570 Vectors for tissue-specific replication |
| 06/26/2003 | US20030118568 Viral stealth technology to prevent T cell-mediated rejection of xenografts |
| 06/26/2003 | US20030118567 Cell-based therapy for the pulmonary system |
| 06/26/2003 | US20030118564 Intra-tumoral administration of il-12 encoding nucleic acid molecules |
| 06/26/2003 | US20030118557 Axon repair |
| 06/26/2003 | US20030118556 Transducing neuron with gene; muscular disorders |
| 06/26/2003 | US20030118554 Helper dependent adenovirus vectors based on integrase family site-specific recombinases |
| 06/26/2003 | US20030118553 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and metastases mediated thereof |
| 06/26/2003 | US20030118552 Targeted retrograde gene delivery for neuronal protection |
| 06/26/2003 | US20030118551 Modified viral surface proteins for binding to extracellular matrix components |
| 06/26/2003 | US20030118550 Compositions and methods for inducing activation of dendritic cells |
| 06/26/2003 | US20030118546 Genetic engineering; polypeptides; antitumor agent |
| 06/26/2003 | US20030118507 Methods of using 46828, a human acyl-CoA synthetase |
| 06/26/2003 | CA2473890A1 Methods and pharmaceutical compositions for gnrh-i and gnrh-ii modulation of t-cell activity, adhesion, migration and extravasation |
| 06/26/2003 | CA2471777A1 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control |
| 06/26/2003 | CA2470640A1 Use of hmgb proteins and nucleic acids that code therefor |
| 06/26/2003 | CA2470322A1 Methods for particle-assisted polynucleotide immunization using a pulsed electric field |
| 06/26/2003 | CA2469799A1 Use of a lysolipid for the preparation of a composition for transfection of a polynucleotide into a cell |
| 06/26/2003 | CA2469785A1 Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor |
| 06/26/2003 | CA2453417A1 Nanoparticle delivery vehicle |
| 06/25/2003 | EP1321526A2 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle |
| 06/25/2003 | EP1321475A1 Gene useful for diagnosis and treatment of aplasia of corpus callosum and aspermatogensis and use thereof |
| 06/25/2003 | EP1321474A1 A method for inducing apoptosis |
| 06/25/2003 | EP1320622A2 Viral vectors having tissue tropism for t-lymphocytes, b- and mast cells |
| 06/25/2003 | EP1320621A2 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
| 06/25/2003 | EP1320619A1 Chimeric vectors and their use for heterologous genes transfer |
| 06/25/2003 | EP1320603A1 Uses of the gjb6 gene for treating certain types of alopecia including the clouston's syndrome, and for screening compounds capable of being efficient in the treatment of alopecia with genetic susceptibility |
| 06/25/2003 | EP1320599A2 Pd-l2 molecules: pd-1 ligands and uses therefor |
| 06/25/2003 | EP1320597A2 Induction of exon skipping in eukaryotic cells |
| 06/25/2003 | EP1320584A2 Transferases |
| 06/25/2003 | EP1320582A2 Adenovirus e1b-55k single amino acid mutants and methods of use |
| 06/25/2003 | EP1320545A2 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen |
| 06/25/2003 | EP1320386A1 A novel cationic lipopolymer as biocompatible gene delivery agent |
| 06/25/2003 | EP1320295A1 Collagen/polysaccharide bilayer matrix |
| 06/25/2003 | EP1235536B1 MEDICAL DEVICE comprising a synthetic surface having nucleic acid for in vivo induction of its endothelialisation |
| 06/25/2003 | EP1140019B1 Aerosol formulations for buccal and pulmonary application |
| 06/25/2003 | EP1019428B1 Inverted chimeric and hybrid oligonucleotides |
| 06/25/2003 | EP0679182B1 Delivery of gene products via mesangial cells |
| 06/25/2003 | EP0678121B1 Methods and reagents for inhibiting furin endoprotease |
| 06/25/2003 | CN1426482A Diagnostics and therapeutics for glaucoma |
| 06/25/2003 | CN1426477A 方法 Method |
| 06/25/2003 | CN1426467A Thrombopoietin receptor modulating peptide |
| 06/25/2003 | CN1426464A Gene of IL-12 p40 subunit mutated for improving activity of IL-12 and use thereof for DNA vaccine adjuvant |
| 06/25/2003 | CN1426462A Pneumovirus NS proteins antagonising interferon (IFN) response |
| 06/25/2003 | CN1426421A Tumour-specific animal proteins |
| 06/25/2003 | CN1426309A Adjuvanted genetic vaccines |
| 06/25/2003 | CN1426307A 蛋白质 Protein |
| 06/25/2003 | CN1426306A Method and compositions for impairing multiplication of HIV-1 |
| 06/25/2003 | CN1425467A Method for regulating replication of nonreplication adenovirus |
| 06/25/2003 | CN1425466A Short interference ribonucleic acid as novel anti-tumor gene therapeutic medicine |
| 06/24/2003 | US6583336 Generation of transgenic plant; obtain cells, incubate with expression vector, transform cells, recover transformed cells, propagate in nutrient broth |
| 06/24/2003 | US6583276 Nucleotide sequences coding polypeptide for use in the treatment of cardiovascular disorders |
| 06/24/2003 | US6583269 Human protease inhibitor and polynucleotides encoding the same |
| 06/24/2003 | US6583149 2-hydroxymethyl-4-(cytosin-1'-yl)-1,3-Dioxolane |
| 06/24/2003 | US6583122 Use in boron neutron capture therapy (BNCT) and diagnostic purposes; treating cancer, viral infections such as HIV, hepatitis B virus |
| 06/24/2003 | US6583121 System for the in vivo delivery and expression of heterologous genes in the bone marrow |
| 06/24/2003 | US6582947 Nucleotide sequences coding enzymatic polypeptide for use in the virus treatment of cancer and viral infection |
| 06/24/2003 | US6582918 Platelet derived growth factor (PDGF) nucleic acid ligand complexes |
| 06/24/2003 | US6582913 Detection of nucleotide sequence polymorphism; obtain nucleotide sequences sampple, determine nucleotide sequence, compare to control, detect adjustment in nucleotide sequences |
| 06/24/2003 | US6582725 Human PEA3 is a tumor suppressor for cancer cells |
| 06/24/2003 | US6582703 Medical diagnosis; amplification primers; genetic engineering |
| 06/24/2003 | US6582694 Method for preparing a viral aerosol |
| 06/24/2003 | US6582693 Recombinant MVA virus expressing the E2 gene of Bovine papillomavirus and its use in the therapy of tumors generated by papillomaviruses |
| 06/24/2003 | US6582692 Recombinant adeno-associated virus virions for the treatment of lysosomal disorders |
| 06/24/2003 | US6582391 Extracorporeal device comprising insoluble collagen fibrils; embedded within matrix are cultured vertebrate cells which secrete polypeptides; shunting patient's blood through apparatus and back into patient; polypeptide mixes with blood |
| 06/24/2003 | CA2223694C Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof |
| 06/19/2003 | WO2003050504A2 Methods and compositions to treat cardiovascular disease usin g 1419, 58765 and 2201 |
| 06/19/2003 | WO2003050311A2 Methods and compositions for diagnosing and treating hypotrichosis simplex |
| 06/19/2003 | WO2003050301A2 Susceptibility locus for schizophrenia |
| 06/19/2003 | WO2003050300A2 Diagnosis and treatment of cancer |
| 06/19/2003 | WO2003050281A2 Fragments of the human zn-alpha2-glycolprotein and their use in methods of treatment of obesity |
| 06/19/2003 | WO2003050271A2 In vitro production of dendritic cells from cd14+ monocytes |
| 06/19/2003 | WO2003050270A1 Method for producing stem cells with increased developmental potential |
| 06/19/2003 | WO2003050262A2 Method for the generation of antigen-specific lymphocytes |
| 06/19/2003 | WO2003050258A2 Endogenous retrovirus polypeptides linked to oncogenic transformation |
| 06/19/2003 | WO2003050255A2 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer |
| 06/19/2003 | WO2003050254A2 Novel chimeric tnf ligands |
| 06/19/2003 | WO2003050251A2 Hematopoietic cells from human embryonic stem cells |
| 06/19/2003 | WO2003050249A2 Islet cells from human embryonic stem cells |
| 06/19/2003 | WO2003050245A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/19/2003 | WO2003050241A2 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation |
| 06/19/2003 | WO2003050238A2 Receptor-targeted adenoviral vectors |
| 06/19/2003 | WO2003050236A2 Human genes and gene expression products isolated from human prostate |
| 06/19/2003 | WO2003050135A2 Use a parapox b2l protein to modify immune responses to administered antigens |
| 06/19/2003 | WO2003049783A2 Device and methods for harvesting tissue samples of known geometry |
| 06/19/2003 | WO2003049773A1 Methods for inhibiting ocular processes |
| 06/19/2003 | WO2003049764A1 Composition for viral preservation |
| 06/19/2003 | WO2003049763A1 Composition for the preservation of viruses |
| 06/19/2003 | WO2003049762A2 Immunisation against chlamydia trachomatis |
| 06/19/2003 | WO2003049703A2 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
| 06/19/2003 | WO2003049700A2 Growth hormone releasing hormone suplementation for treating chronically ill subjects |
| 06/19/2003 | WO2003049683A2 Use of parapox b2l protein to treat cancer and modify immune responses |
| 06/19/2003 | WO2003049626A1 Method and apparatus for production of a skin graft and the graft produced thereby |
| 06/19/2003 | WO2003028657A3 Compositions for oral gene therapy and methods of using same |
| 06/19/2003 | WO2002094996A8 Ccl1 polynucleotides and polypeptides and uses thereof |
| 06/19/2003 | WO2002094864A3 Human cdnas and proteins and uses thereof |
| 06/19/2003 | WO2002030979A3 Polypeptides homologous to thymosin, ephrin a receptors, and fibromodulin, and polynucleotides encoding same |
| 06/19/2003 | WO2002029058A3 Human proteins, polynucleotides encoding them and methods of using the same |